A Phase Ib/II Study of Galunisertib in Combination with Nivolumab in Solid Tumors and Non-Small Cell Lung Cancer
BMC Cancer(2023)
关键词
Galunisertib,Immune checkpoint inhibitor,Nivolumab,NSCLC,TGF-β
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
BMC Cancer(2023)